About 2050 Capital is a tech investment company that focuses on transformative and defensible innovation in enterprise software, computational biotech, and engineering and science ventures. Their disciplined and surgical investment approach, backed by deep domain expertise, supports breakthrough technologies.
2050 Capital invests in transformative and defensible innovation that impacts large fundamental sectors, focusing on enterprise software (with a deep science component), computational biotech, and engineering and science ventures.
Top-tier fund specializing in early-stage technology investments across North America and Europe. Completed over 30 deals, with several notable exits including successful IPOs. Renowned for an operator-led investment style, providing hands-on support to entrepreneurs. Strategic and focused on high-growth potential sectors.